A particular case, page-26

When announcing FDA approval, EZZ stated they plan to replicate their business model in other jurisdictions by using online media to grow sales in the US. But another part of their Omni channel model is of course signing up third party distributors to multi-year contracts, a la Pinehills. That effectively outsources all marketing to already established and much larger businesses, in addition to distribution. Hence it significantly derisks entry into a new market. I would imagine that EZZ will want to do the same in the US. Should they be successful in finding such a partner, and should the partner be a large and thriving business, I would expect the share price to rocket. I have been adding to my holding recently as the upside from such a development outweighs any risk of temporary share price weakness due to profit taking.